Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dinepat203 dinepat203 Dec 12, 2012 8:00 PM Flag

    OPEN AT $16

    Creating a solid foundation for Genzyme's future growth, our R&D efforts include novel therapeutic candidates as well as new indications for our existing products. Explore our pipeline to see highlights of our most promising research. Mipomersen* Homozygous and severe heterozygous familial hypercholesterolemia( Oligonucleotide)

 
ISIS
51.93+0.18(+0.35%)3:11 PMEDT